112
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy

, , , &
Pages 145-150 | Published online: 27 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Potchavit Aphinives, Damnern Vachirodom, Chaiyut Thanapaisal, Dhanes Rangsrikajee & Ongart Somintara. (2015) A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients. Breast Cancer: Targets and Therapy 7, pages 37-41.
Read now

Articles from other publishers (2)

Imjai Chitapanarux, Wimrak Onchan, Panchaporn Wongmaneerung, Areewan Somwangprasert, Nongnuch Bunyoo, Chagkrit Ditsatham, Kirati Watcharachan, Chaiyut Charoentum, Patumrat Sripan, Ausreeya Chumachote & Puttachart Maneesai. (2022) Integration of breast cancer care in a middle-income country: learning from Suandok Breast Cancer Network (SBCN). BMC Cancer 22:1.
Crossref
Yanyan Liu, Huining Yi, Kexin Fang, Yuwen Bao & Xin Li. (2022) Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis. Frontiers in Public Health 10.
Crossref